| Scheme |
Details |
Typical timelines and budget |
| BHF Translational Award |
Supports the pre-clinical development of new cardiovascular medicines and technologies so that they are attractive for follow-on funding: bridging the funding gap between promising innovations and the clinic |
£750k. |
| CRUK Innovation Prize |
Develop the translational and commercial potential of research |
One year, £50k |
| CRUK Small Molecule Drug Discovery Project Awards |
Identify and characterise small molecule novel therapeutic targets and to identify and develop novel therapeutic entities for the benefit of cancer patients. New target identification & validation. |
One to three years, £100k p.a. |
| Innovate UK |
Multiple schemes which are updated regularly, ranging from small innovation vouchers to large, collaborative programmes. Usually industry-led. |
Various |
| MRC Biomedical catalyst |
Early stage, small molecule, drug discovery. Will fund development of therapeutics. |
Up to three years, £3M |
| Wellcome Trust Innovator Awards |
For the development of healthcare innovations that could have a significant impact on human health. |
Up to two years, £500k (£750k for multidisciplinary projects) |
| Worldwide Cancer Research |
Funding for basic and translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer |
12-36 months, £250k |
